Cost-Effectiveness of Disease- Modifying Therapies in Multiple Sclerosis: A Managed Care Perspective

Supplements and Featured Publications, Cost-Effectiveness of Disease- Modifying Therapies in Multiple Sclerosis: A Managed Care Perspective, Volume 22, Issue 6 Suppl

Publishing Staff

Senior Vice President of Operations and Clinical Affairs

Jeff D. Prescott, PharmD, RPh

Senior Clinical Projects Manager

Ida Delmendo

Clinical Projects Manager

Cindy Spielvogel

Project Manager

Jessica Toye

Proofreaders

Griselda Demassey

Maggie Shaw

Associate Editor

Jeanne Linke

Assistant Editor

Sarah Anwar

Clinical Editor

Michael R. Page, PharmD, RPh

Designer

Julianne Costello

Associate Publisher

Justin T. Gallagher

Director of Sales

Sara Belanger

National Account Managers

Gabrielle Consola

Michael Costella

Corporate

Chairman and CEO

Mike Hennessy, Sr

Vice Chairman

Jack Lepping

President

Mike Hennessy, Jr

Chief Operating Officer/CFO

Neil Glasser, CPA/CFE

President, Managed Markets, Pharmacy,and Rare Disease

Brian Haug

Executive Vice President and General Manager

John Maglione

Chief Creative Officer

Jeff Brown

Human Resources Director

Shari Lundenberg

President, Pharmacy Times Continuing Education

David Heckard

PARTICIPATING FACULTY

Faculty

Jacquelyn Bainbridge, BSPharm, PharmD

Professor

Department of Clinical Pharmacy

Skaggs School of Pharmacy and Pharmaceutical Sciences

Department of Neurology

School of Medicine

Anschutz Medical Campus

University of Colorado

Aurora, Colorado

Felecia M. Hart, PharmD

Clinical Neurology Research Fellow

Department of Clinical Pharmacy

Skaggs School of Pharmacy and Pharmaceutical Sciences

University of Colorado

Aurora, Colorado

Samuel F. Hunter, MD, PhD

President

Advanced Neurosciences Institute

Franklin, Tennessee

University Director

NeuroNexus Center

Neurology Research at the Novel Pharmaceutics Institute

Franklin, Tennessee

Clinical Assistant Professor

Department of Neurology

Vanderbilt University School of Medicine

Nashville, Tennessee

Gary M. Owens, MD

President

Gary Owens Associates

Ocean View, Delaware

Editorial Support

Karen Golebowski, MS

President and Principal Biomedical Writer

Write Rite, Inc

Lopatcong, New Jersey

Cynthia L. Kryder, MS, CCC-Sp

Medical Communications Consultant

Phoenixville, Pennsylvania

Elizabeth Paczolt, MD, FACNM

Medical Consultant

Churchville, Pennsylvania

Faculty Disclosures

These faculty report relationships with the following organizations:

Samuel F. Hunter, MD, PhD

Consultant:

AbbVie, Bayer, Genentech/Roche, Sanofi-Genzyme

Multicenter clinical research trial participation:

Adamas, Biogen, Genentech/Roche, Teva

Research grant support:

Sanofi-Genzyme

Speakers’ Bureau:

Mallinckrodt, Novartis, Sanofi-Genzyme, Teva

Gary Owens, MD

Consultant:

Biogen, Genentech/Roche, Genzyme, Novartis

Honoraria:

Biogen, Genentech/Roche, Genzyme, Novartis

Jacquelyn Bainbridge, BSPharm, PharmD, and Felecia M. Hart, PharmD, have no relevant financial relationships with commercial interests to disclose.

Editorial Support Discloures

Karen Golebowski, MS; Cynthia L. Kryder, MS, CCC-Sp;

Elizabeth Paczolt, MD, FACNM,

and have no relevant financial relationships with commercial interests to disclose.

The American Journal of Managed Care

Publishing Staff—Jeff D. Prescott, PharmD, RPh; Ida Delmendo; and Cindy Spielvogel have no relevant financial relationships with commercial interests to disclose.

Pharmacy Times Continuing Education

Planning Staff—Dave Heckard; Maryjo Dixon, RPh; Neelam Davis, PharmD; Donna Fausak; Nathalie Harden; and Tara DeLorenzo have no relevant financial relationships with commercial interests to disclose.

Disclosure Policy

According to the disclosure policy of The American Journal of Managed Care and Pharmacy Times Continuing Education, all persons who are in a position to control content are required to disclose any relevant financial relationships with commercial interests. If a conflict is identified, it is the responsibility of Pharmacy Times Continuing Education to initiate a mechanism to resolve the conflict(s). The existence of these relationships is not viewed as implying bias or decreasing the value of the activity. All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.

Disclosure of Unapproved/Off-Label Use

The contents of this activity may include information regarding the use of products that may be inconsistent with or outside the approved labeling for these products in the United States. Participants should

note that the use of these products outside current approved labeling is considered experimental and are advised to consult prescribing information for these products. The information provided in this CE activity is for continuing medical and pharmacy education purposes only and is not meant to substitute for the independent medical or pharmacy judgment of a physician or pharmacist relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of The American Journal of Managed Care, Pharmacy Times Continuing Education, or any of the companies that provided commercial support for this CE activity.